Dsip 10 Mg
Delta Sleep-Inducing Peptide (DSIP) 10 mg is a highly purified, synthetic nonapeptide isolated for laboratory investigation into slow-wave sleep mechanisms and neuroendocrine modulation. Evaluated extensively in preclinical models, DSIP serves as a vital tool for analyzing central nervous system regulation, electroencephalographic delta activity, and stress-axis responses.
Quick answer
Delta Sleep-Inducing Peptide (DSIP) 10 mg is a highly purified, synthetic nonapeptide isolated for laboratory investigation into slow-wave sleep mechanisms and neuroendocrine modulation. Evaluated extensively in preclinical models, DSIP serves as a vital tool for analyzing central nervous system regulation, electroencephalographic delta activity, and stress-axis responses.
Key takeaways
- DSIP 10 mg represents a high-purity, lyophilized 10-milligram quantity of Delta Sleep-Inducing Peptide, a synthetic nonapeptide (sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) designated strictly for laboratory research.
- Delta Sleep-Inducing Peptide was first isolated from the hemodialysate of sleeping rabbits in 1977.
- The primary mechanism of action documented for DSIP centers on its capacity to promote slow-wave, delta-phase sleep (0.5–4 Hz electroencephalographic activity) without altering the natural sleep architecture.
- Beyond its central electroencephalographic effects, DSIP functions as a potent modulator of the hypothalamic-pituitary-adrenal (HPA) axis.
Direct Answer: What is DSIP 10 mg?
DSIP 10 mg represents a high-purity, lyophilized 10-milligram quantity of Delta Sleep-Inducing Peptide, a synthetic nonapeptide (sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu) designated strictly for laboratory research. Preclinical literature demonstrates its capacity to modulate electroencephalographic delta-wave sleep patterns, attenuate hypothalamic-pituitary-adrenal (HPA) axis stress activity, and support physiological recovery processes in animal models without inducing generalized CNS depression.
When purchasing DSIP 10 mg for in vitro or animal research protocols, investigators require precise structural validation, high sequence fidelity, and strict absence of bacterial endotoxins to ensure reproducible physiological and biochemical datasets.
Molecular Structure and Biochemical Profile of Delta Sleep-Inducing Peptide
Delta Sleep-Inducing Peptide was first isolated from the hemodialysate of sleeping rabbits in 1977. Chemically classified as a nonapeptide, its structural motif consists of nine amino acids with a molecular weight of approximately 848.81 g/mol. Unlike classic sedative compounds that operate through direct gamma-aminobutyric acid (GABA) receptor agonism, DSIP exhibits a complex, multi-target neuromodulatory profile that spans central neuronal pathways and peripheral endocrine cascades.
In laboratory settings, researchers examine the nonapeptide's unique amphipathic structure, which permits interactions with both cell-surface receptors and intracellular signaling cascades. Studies utilizing research peptides targeting the central nervous system emphasize the necessity of precise molecular folding and analytical verification to prevent aggregation or cleavage during experimental assays.
Primary Mechanism of Action: Delta-Wave Sleep Induction and Neurological Pathways
The primary mechanism of action documented for DSIP centers on its capacity to promote slow-wave, delta-phase sleep (0.5–4 Hz electroencephalographic activity) without altering the natural sleep architecture. Preclinical electroencephalographic (EEG) recordings in rodent and feline models indicate that DSIP administration increases the duration and power density of slow-wave sleep phases while leaving rapid eye movement (REM) phases intact.
In vitro data indicate that DSIP interacts with central peptidergic circuits, modulating the release of monoamines such as serotonin and norepinephrine within hypothalamic nuclei. Preclinical studies suggest that this selective modulation allows researchers to investigate sleep-wake regulation without the neurochemical disruption or tolerance development typically associated with small-molecule hypnotic agents.
Neuroendocrine Modulation and HPA Axis Regulation
Beyond its central electroencephalographic effects, DSIP functions as a potent modulator of the hypothalamic-pituitary-adrenal (HPA) axis. During acute and chronic stress models in preclinical rodent assays, DSIP has been observed to suppress elevated basal adrenocorticotropic hormone (ACTH) and corticosterone levels.
Laboratory investigations reveal that DSIP exerts a stabilizing effect on pituitary hormone secretion. It suppresses stress-induced hypercortisolemia while maintaining normal physiological release of luteinizing hormone (LH) and somatotropin (growth hormone). This dual action makes DSIP 10 mg an important asset for researchers analyzing stress-induced neuroendocrine dysregulation and systemic recovery pathways during rest cycles.
Preclinical Findings in Physiological Recovery and Oxidative Stress
In addition to sleep architecture, preclinical trials highlight DSIP's role in mitigating oxidative stress and cellular damage during physiological strain. Rodent models subjected to hypoxia or metabolic stress exhibited reduced lipid peroxidation and maintained higher levels of endogenous antioxidant enzymes—such as superoxide dismutase (SOD) and glutathione peroxidase—when treated with DSIP.
These observations indicate that DSIP's physiological role extends beyond immediate somnogenic actions to encompass tissue-level cytoprotection and metabolic stabilization. Researchers investigating cellular recovery mechanisms frequently incorporate DSIP into protocols exploring mitochondrial protection, ischemic preconditioning, and stress resilience.
Comparative Analysis: DSIP vs. Epithalon and Neuroactive Peptides
To properly contextualize DSIP within peptide research, investigators frequently compare its signaling profile against other regulatory nonapeptides and neuroactive compounds. While DSIP acts primarily on delta-wave sleep induction and HPA-axis damping, compounds like Epithalon 10 mg focus on telomerase activation, pineal gland regulation, and circadian rhythm entrainment. Similarly, Selank and Semax exert pronounced anxiolytic and neurotrophic effects through brain-derived neurotrophic factor (BDNF) up-regulation, contrasting with DSIP's specific focus on somnogenic electrophysiology.
Understanding these functional distinctions allows research facilities to design targeted comparative studies. While Selank and Semax modulate cognitive processing and acute stress responses, DSIP remains the primary candidate for assays specifically dissecting deep slow-wave sleep propagation and basal neuroendocrine suppression.
Laboratory Handling, Reconstitution, and Solubilization Protocol
Lyophilized DSIP 10 mg requires careful reconstitution protocols to maintain peptide stability and prevent physical degradation. Standard laboratory practice dictates solubilizing the lyophilized powder in sterile Bacteriostatic Water (0.9% benzyl alcohol) or sterile normal saline (0.9% NaCl), depending on downstream cellular or animal assay requirements.
To reconstitute, allow the glass vial to reach room temperature prior to solvent introduction. Direct the solvent stream down the inner glass wall rather than directly onto the lyophilized cake. Gently swirl the vial until complete dissolution is achieved; aggressive agitation or vortexing must be avoided to prevent shear stress and peptide denaturation. Reconstituted solutions should be aliquoted into single-use polypropylene microtubes to eliminate freeze-thaw cycles and stored at -20°C or -80°C for long-term experimental consistency.
Analytical Quality Control: RP-HPLC, Mass Spectrometry, and Endotoxin Standards
Reliable preclinical outcomes depend entirely on the purity and structural integrity of the research compound. PX1 Research subjects every lot of DSIP 10 mg to rigorous analytical testing, confirming both chemical identity and high purity standards in compliance with ISO 17025 accredited methods.
Purity is validated via Reversed-Phase High-Performance Liquid Chromatography (RP-HPLC), ensuring a minimum purity threshold of ≥98%. Molecular weight and sequence sequence integrity are confirmed through Electrospray Ionization Mass Spectrometry (ESI-MS). Furthermore, every batch undergoes Limulus Amebocyte Lysate (LAL) testing to verify that bacterial endotoxin levels remain below strictly defined limits (<0.01 EU/mg), preventing confounding inflammatory responses in sensitive cell cultures or animal models.
Storage and Stability Guidelines for Laboratory Reagents
Proper storage conditions are critical to preserving the bioactivity of DSIP 10 mg throughout its experimental lifecycle. Upon receipt, lyophilized vials should be kept in a desiccated environment at -20°C for short-term storage (up to 12 months) or -80°C for extended stability. Exposure to ambient light, moisture, and elevated temperatures accelerates peptide bond hydrolysis and methionine oxidation.
Once reconstituted, working solutions maintained at 2°C to 8°C should be utilized within 14 days if formulated with a bacteriostatic agent. For non-preserved aqueous solutions, immediate experimental use or sub-zero storage (-20°C or colder) is required. Detailed handling specifications and safety data sheets are maintained within our research library for laboratory personnel reference.
Institutional Procurement and Sourcing at PX1 Research
PX1 Research is an established USA-based manufacturer and supplier dedicated to supporting academic institutions, biotechnology organizations, and independent scientific laboratories. All peptide compounds are synthesized in state-of-the-art, GMP-compliant facilities located within the United States, guaranteeing lot-to-lot consistency, full traceability, and complete batch documentation.
To support high-throughput testing and multi-phase research initiatives, PX1 Research provides tier pricing and supply chain reliability via our wholesale laboratory program. Orders are processed with same-day fulfillment (Monday through Friday) and shipped directly from our primary distribution hubs in California and Arizona, ensuring rapid transit times and temperature-controlled integrity upon arrival.
Frequently Asked Questions
What is the primary research application of DSIP 10 mg?
DSIP 10 mg is primarily utilized in preclinical studies evaluating slow-wave (delta) sleep induction, neuroendocrine regulation, HPA axis stress modulation, and cellular recovery mechanisms during physiological rest.
Is DSIP 10 mg approved for human clinical use or administration?
No. DSIP 10 mg is sold strictly as a laboratory research compound for in vitro assays and animal models. It is not intended, labeled, or approved for human consumption, medical treatment, or clinical use.
How should lyophilized DSIP 10 mg be stored upon receipt?
Lyophilized DSIP should be stored at -20°C in a dry, dark environment upon arrival. For long-term storage exceeding 12 months, temperature control at -80°C is recommended to maintain chemical stability.
What reconstituted diluent is recommended for DSIP 10 mg?
Reconstitution is typically performed using sterile Bacteriostatic Water (0.9% benzyl alcohol) for multi-use laboratory protocols or sterile 0.9% sodium chloride (saline) for immediate in vivo or cell culture application.
How is the purity of PX1 Research DSIP 10 mg verified?
Every lot undergoes independent laboratory testing via RP-HPLC to confirm a purity level of ≥98% and ESI-MS to verify exact molecular weight. A lot-specific Certificate of Analysis (COA) is provided with each shipment.
What are the endotoxin specifications for DSIP 10 mg?
PX1 Research enforces strict endotoxin testing using standard LAL assays to ensure endotoxin content remains below <0.01 EU/mg, preventing unwanted immunogenic responses in research models.
How does DSIP differ from other neuroactive research peptides like Selank or Epithalon?
DSIP specifically target delta-wave sleep induction and HPA-axis suppression. Epithalon acts primarily on pineal function and telomerase expression, while Selank operates as an anxiolytic via BDNF pathways.
What shipping options and origins are used for DSIP 10 mg orders?
All orders ship directly from PX1 Research distribution facilities located in California and Arizona. Orders placed Monday through Friday before standard cut-off times are dispatched same-day in protective thermal packaging.
Related pages
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.